Prevacid lansoprazole: Phase IV data

The double-blind, U.S. Phase IV SARCA trial in 306 patients aged 6-17 with poorly controlled asthma who were receiving inhaled corticosteroids (ICS) showed that once-daily oral lansoprazole missed the...